Floatz logo

Degarelix

Prostate Carcinoma

Baptist Health South Floridaprotein_peptidePhase 3Active
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
89/ 100

Competitive context

107 Active assets in the Prostate Carcinoma cohort.

Asset / SponsorPhaseRating
Leuporelin
Mayo Clinic
Phase 4BBB
Enzalutamide
Pfizer
Phase 4BBB
Prednisone
Mayo Clinic
Phase 4BBB
Abiraterone
Mayo Clinic
Phase 4BBB
Docetaxel
Alliance for Clinical Trials in Oncology
Phase 3BB

View all 49 →

Same molecule, other indications

Degarelix is also rated in:

prostate cancerActive
BBB
Indicative · Phase 4
72 / 100
View asset →
prostate neoplasmActive
BBB
Indicative · Phase 4
72 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →